What is Ibogaine?
Ibogaine is a compound found in the leaves of an African shrub called Iboga, and studies indicate it may have anti-addictive properties.
Articles - Page 13
Single Ketamine Dose Could Help to Treat Problematic Drinking Behavior
New research suggests that ketamine can aid in reorganizing alcohol-related memories.
Scientists Test the Effects of Inhaling Synthetic 5-MeO-DMT
Some changes occured to biomarkers for stress and inflammation. The subjective effects reveal more evidence of the entourage effect.
COMPASS Patent Highlights Importance of Crystallography in Psychedelic Drug Development
The scope and validity of this patent will depend on how x-ray diffraction data is interpreted.
Placebo-Controlled Study Finds Psilocybin Formulation is Safe and Well-Tolerated in Healthy Volunteers
The study used an investigational psilocybin formulation called COMP360 developed and produced by COMPASS Pathways.
Study Identifies Compounds and Mechanism that Causes Psilocybin Mushroom Bluing
These bluing compounds can exist as dimeric, trimeric, and tetrameric forms of psilocin and/or its structural analogs.
Altered Oscillations: The Modulatory Effect of DMT on Brain Waves
A recent Nature paper provides novel insights into the neural correlates of the Breakthrough Experience associated with DMT.
Study Finds ALD-52, 1P-LSD, and 1B-LSD Are Prodrugs of LSD
Identifying and understanding prodrugs is an essential component of psychedelic drug research.
New Zealand’s Ministry of Health Approves LSD Microdosing Study
The study will examine the effects of microdosing LSD on the everyday lives of the participants.
Denver Mayor Creates Psilocybin Mushroom Policy Review Panel
Coming on the heels of the passing of their magic mushroom decriminalization measure in May, the city of Denver, Colorado has created the world’s first Psilocybin Mushroom Policy Review Panel...